Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Clinical trial NCT06517875 · RECRUITING

Trial details

NCT number: NCT06517875
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis

Start date: 2025-02-28
Primary completion: 2027-03-19
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.